Agonistic anti-CD40 antibody treatment converts resident regulatory T cells into activated type 1 effectors within the tumor microenvironment
Vivien I. Maltez, Charu Arora, Kyle P. Gribbin, Breanna Caruso et autres
us (code pays fourni par la source)
2 citations
Immunity